when science meets nature
Public studies on ingredientsAnimal Study, Bacterial, Human In Vitro, Human Study, In Vitro Study.
GANODERMA LUCIDUM (REISHI)
Research & Studies
Ganoderma lucidum Polysaccharides as An Anti-cancer Agent
The mushroom Ganoderma lucidum (G. lucidum) has been used for centuries in Asian countries to treat various diseases and to promote health and longevity. Clinical studies have shown beneficial effects of G. lucidum as an alternative adjuvant therapy in cancer patients without obvious toxicity. G. lucidum polysaccharides (GLP) is the main bioactive component in the water soluble extracts of this mushroom. Evidence from in vitro and in vivo studies has demonstrated that GLP possesses potential anticancer activity through immunomodulatory, anti-proliferative, pro-apoptotic, anti-metastatic and anti-angiogenic effects. Here, we briefly summarize these anticancer effects of GLP and the underlying mechanisms.
Keywords: Ganoderma lucidum polysaccharides; Reishi; anti-angiogenic; anti-cancer; anti-metastatic; anti-proliferative; immunomodulatory; pro-apoptotic..
HEALTH BENEFITS OF MEDICINAL MUSHROOMS
While much attention in recent years has focused on various immunological and anti-cancer properties of certain mushrooms, they also offer other potentially important health benefits, including antioxidants, anti-hypertensive and cholesterol-lowering properties, liver protection, as well as anti-inflammatory, anti-diabetic, anti-viral and anti-microbial properties. These properties have attracted the interest of many pharmaceutical companies, which are viewing the medicinal mushroom as a rich source of innovative biomedical molecules.
PubMed comprises more than 28 million citations for biomedical literature from MEDLINE, life science journals, and online books.
There are 1357 on GANODERMA LUCIDUM (REISHI)